Sugi Predict

Sugi Predict / Compounds / SCHEMBL4646869

SCHEMBL4646869

SCHEMBL4646869

NC(=O)c1ccc(-c2ccc(Br)c(S(=O)(=O)N[C@@H](CO)Cc3c[nH]c4ccccc34)c2)cc1Cl

nearest known ligand 0.47

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
▸ NEK1 Q96PY6 2/20 0.47
▸ NR3C1 P04150 11/20 0.47
▸ NR3C2 P08235 3/20 0.46
▸ PGR P06401 2/20 0.46
▸ KMT2A Q03164 2/20 0.46
▸ MEN1 O00255 1/20 0.44
▸ POLB P06746 1/20 0.44
▸ MMP2 P08253 3/20 0.43
▸ MMP9 P14780 3/20 0.43
▸ ITGB2 P05107 1/20 0.43
▸ ICAM1 P05362 1/20 0.43
▸ ITGAL P20701 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4647372 0.82 MEN1 (0.48) NEK1NR3C1NR3C2PGRKMT2A
SCHEMBL4648904 0.81 NR3C1 (0.52) NEK1NR3C1NR3C2PGRKMT2A
SCHEMBL4685322 0.80 NR3C1 (0.47) NEK1NR3C1NR3C2PGRKMT2A
SCHEMBL4647690 0.80 NR3C1 (0.47) NEK1NR3C1NR3C2PGRKMT2A
SCHEMBL4649023 0.79 NEK1 (0.55) NEK1NR3C1NR3C2PGRMMP2
SCHEMBL4646109 0.79 NR3C1 (0.47) NEK1NR3C1NR3C2PGRKMT2A
SCHEMBL4648789 0.79 NR3C1 (0.49) NEK1NR3C1NR3C2PGRKMT2A
SCHEMBL4648410 0.78 NEK1 (0.56) NEK1NR3C1NR3C2PGRKMT2A
SCHEMBL4645638 0.77 NR3C1 (0.42) NEK1NR3C1NR3C2PGRKMT2A
SCHEMBL4645621 0.77 NR3C1 (0.47) NR3C1NR3C2PGRKMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080255117-A1 SULFONYLTRYPTOPHANOLS BAYER SCHERING PHARMA AG (DE) 2008-10-16 — — US claimed
WO-2008104597-A2 SULFONYLTRYPTOPHANOLS BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) 2008-09-04 — — WO claimed
EP-1964834-A1 Sulphonyltryptophanols Bayer Schering Pharma Aktiengesellschaft (DE) 2008-09-03 — — EP claimed
US-20080255117-A1 SULFONYLTRYPTOPHANOLS BAYER SCHERING PHARMA AG (DE) 2008-10-16 — — US disclosed
US-20080255117-A1 SULFONYLTRYPTOPHANOLS BAYER SCHERING PHARMA AG (DE) 2008-10-16 — — US disclosed
US-20080255117-A1 SULFONYLTRYPTOPHANOLS BAYER SCHERING PHARMA AG (DE) 2008-10-16 — — US disclosed
WO-2008104597-A2 SULFONYLTRYPTOPHANOLS BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) 2008-09-04 — — WO disclosed
WO-2008104597-A2 SULFONYLTRYPTOPHANOLS BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) 2008-09-04 — — WO disclosed
EP-1964834-A1 Sulphonyltryptophanols Bayer Schering Pharma Aktiengesellschaft (DE) 2008-09-03 — — EP disclosed
EP-1964834-A1 Sulphonyltryptophanols Bayer Schering Pharma Aktiengesellschaft (DE) 2008-09-03 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080255117-A1 SULFONYLTRYPTOPHANOLS FSHR, NPY1R, GNRHR NEK1 4534/4885NR3C1 932/4885NR3C2 725/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.